Also trades as: KNE.V (TSXV) · $vol 0M
KNBIF OTC
Kane Biotech Inc.
1W: +3.2%
1M: -0.2%
3M: -5.3%
YTD: -30.6%
1Y: -43.7%
3Y: -75.4%
5Y: -89.8%
$0.02
-0.00 (-2.79%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$2M
+1296.8% ▲
5Y CAGR: +4.2%
Gross Profit
$872K
+696.7% ▲
5Y CAGR: +7.4%
Operating Income
-$4M
-16.8% ▼
Net Income
$6M
+221.1% ▲
EPS (Diluted)
$-0.02
+34.3% ▲
EBITDA
-$4M
-14.6% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $1M | $2M | $3M | $149K | $2M |
| YoY Growth | -20.8% | +19.8% | +66.0% | -94.4% | +1296.8% |
| Cost of Revenue | $815K | $1M | $1M | $40K | $1M |
| Gross Profit | $527K | $568K | $1M | $109K | $872K |
| Gross Margin | 39.3% | 35.4% | 53.0% | 73.5% | 41.9% |
| R&D Expenses | $1M | $1M | $1M | $1M | $2M |
| SG&A Expenses | $3M | $4M | $4M | $2M | $3M |
| Operating Expenses | $5M | $5M | $5M | $3M | $5M |
| Operating Income | -$4M | -$5M | -$3M | -$3M | -$4M |
| Operating Margin | -314.9% | -303.7% | -129.6% | -2253.6% | -188.5% |
| Interest Expense | $122K | $416K | $817K | $1M | $545K |
| Income Before Tax | -$4M | -$5M | -$4M | -$5M | -$4M |
| Tax Expense | $0 | $0 | $0 | $0 | -$1M |
| Net Income | -$4M | -$5M | -$4M | -$5M | $6M |
| Net Margin | -277.0% | -286.4% | -145.8% | -3379.0% | 293.0% |
| EPS (Diluted) | $-0.03 | $-0.04 | $-0.03 | $-0.04 | $-0.02 |
| EBITDA | -$4M | -$4M | -$3M | -$3M | -$4M |
| Shares Outstanding | 108M | 113M | 121M | 127M | 134M |